
Patterson Companies (PDCO) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jan 2025Income Metrics
Revenue
1.6B
Gross Profit
320.8M
20.40%
Operating Income
45.4M
2.89%
Net Income
31.2M
1.98%
EPS (Diluted)
$0.35
Balance Sheet Metrics
Total Assets
2.8B
Total Liabilities
1.8B
Shareholders Equity
989.9M
Debt to Equity
1.86
Cash Flow Metrics
Operating Cash Flow
-289.0M
Free Cash Flow
-296.6M
Revenue & Profitability Trend
Patterson Companies Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 6.6B | 6.5B | 6.5B | 5.9B | 5.5B |
Cost of Goods Sold | 5.2B | 5.1B | 5.2B | 4.7B | 4.3B |
Gross Profit | 1.4B | 1.4B | 1.3B | 1.2B | 1.2B |
Gross Margin % | 21.0% | 21.2% | 19.8% | 20.4% | 21.8% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | - | - | - |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 0 | 0 | 0 | 0 | 0 |
Operating Income | 252.9M | 276.0M | 157.0M | 210.6M | 102.9M |
Operating Margin % | 3.9% | 4.3% | 2.4% | 3.6% | 1.9% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 44.9M | 33.6M | 20.3M | 24.3M | 41.8M |
Other Non-Operating Income | 35.0M | 27.8M | 129.5M | 13.6M | -651.6M |
Pre-tax Income | 243.1M | 270.2M | 266.3M | 199.9M | -590.4M |
Income Tax | 57.5M | 63.6M | 64.5M | 44.8M | -1.0M |
Effective Tax Rate % | 23.7% | 23.5% | 24.2% | 22.4% | 0.0% |
Net Income | 185.5M | 206.6M | 201.7M | 155.1M | -589.4M |
Net Margin % | 2.8% | 3.2% | 3.1% | 2.6% | -10.7% |
Key Metrics | |||||
EBITDA | 341.1M | 359.7M | 239.0M | 289.5M | 185.1M |
EPS (Basic) | $2.00 | $2.14 | $2.09 | $1.63 | $-6.25 |
EPS (Diluted) | $1.98 | $2.12 | $2.06 | $1.61 | $-6.25 |
Basic Shares Outstanding | 92969000 | 97027000 | 97277000 | 95599000 | 94154000 |
Diluted Shares Outstanding | 92969000 | 97027000 | 97277000 | 95599000 | 94154000 |
Income Statement Trend
Patterson Companies Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 114.5M | 159.7M | 142.0M | 143.2M | 77.9M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 547.3M | 477.4M | 447.2M | 449.2M | 416.5M |
Inventory | 782.9M | 795.1M | 785.6M | 736.8M | 812.2M |
Other Current Assets | 334.1M | 351.0M | 304.2M | 286.7M | 236.1M |
Total Current Assets | 1.8B | 1.8B | 1.7B | 1.6B | 1.5B |
Non-Current Assets | |||||
Property, Plant & Equipment | 122.3M | 93.0M | 70.7M | 77.2M | 79.0M |
Goodwill | 505.9M | 544.7M | 533.9M | 559.5M | 591.0M |
Intangible Assets | 193.3M | 231.9M | 252.6M | 279.6M | 313.5M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 250.7M | 242.5M | 246.3M | 313.8M | 234.9M |
Total Non-Current Assets | 1.1B | 1.1B | 1.1B | 1.1B | 1.2B |
Total Assets | 2.9B | 2.9B | 2.7B | 2.8B | 2.7B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 745.4M | 725.0M | 681.3M | 609.3M | 862.1M |
Short-term Debt | 341.6M | 109.4M | 58.3M | 186.0M | 30.7M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 1.3B | 1.1B | 1.0B | 1.1B | 1.1B |
Non-Current Liabilities | |||||
Long-term Debt | 421.4M | 518.6M | 531.9M | 535.9M | 637.6M |
Deferred Tax Liabilities | 104.5M | 119.1M | 120.4M | 124.5M | 134.5M |
Other Non-Current Liabilities | 36.6M | 37.5M | 31.0M | 36.8M | 31.8M |
Total Non-Current Liabilities | 562.4M | 675.3M | 683.3M | 697.2M | 804.0M |
Total Liabilities | 1.9B | 1.8B | 1.7B | 1.8B | 1.9B |
Equity | |||||
Common Stock | 897.0K | 964.0K | 968.0K | 968.0K | 959.0K |
Retained Earnings | 831.5M | 972.1M | 921.7M | 855.7M | 799.7M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.0B | 1.1B | 1.0B | 964.7M | 836.4M |
Key Metrics | |||||
Total Debt | 762.9M | 628.0M | 590.2M | 721.9M | 668.3M |
Working Capital | 446.2M | 697.8M | 663.4M | 526.3M | 467.9M |
Balance Sheet Composition
Patterson Companies Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 185.5M | 206.6M | 201.7M | 155.1M | -589.4M |
Depreciation & Amortization | 88.2M | 83.7M | 82.0M | 78.9M | 82.2M |
Stock-Based Compensation | 17.9M | 15.5M | 23.8M | - | - |
Working Capital Changes | -1.1B | -1.0B | -1.2B | -1.1B | -419.1M |
Operating Cash Flow | -789.1M | -736.6M | -854.3M | -849.4M | -949.1M |
Investing Activities | |||||
Capital Expenditures | -67.6M | -64.2M | -38.3M | -25.8M | -41.8M |
Acquisitions | -1.1M | -33.3M | -19.8M | 0 | 0 |
Investment Purchases | 0 | -15.0M | 0 | 0 | - |
Investment Sales | 0 | 0 | 75.9M | 396.0K | 0 |
Investing Cash Flow | 959.5M | 901.6M | 1.2B | 810.7M | 499.1M |
Financing Activities | |||||
Share Repurchases | -229.5M | -55.5M | -35.0M | 0 | 0 |
Dividends Paid | -98.3M | -101.3M | -101.1M | -75.2M | -100.4M |
Debt Issuance | - | - | 0 | 0 | 300.0M |
Debt Repayment | -36.0M | -1.5M | -100.8M | 0 | -460.8M |
Financing Cash Flow | -215.9M | -126.5M | -253.2M | -22.6M | -271.2M |
Free Cash Flow | -857.0M | -819.1M | -1.0B | -756.3M | -285.4M |
Net Change in Cash | -45.5M | 38.5M | 131.5M | -61.4M | -721.2M |
Cash Flow Trend
Patterson Companies Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
20.48
Forward P/E
12.43
Price to Book
2.80
Price to Sales
0.43
PEG Ratio
12.43
Profitability Ratios
Profit Margin
2.13%
Operating Margin
3.06%
Return on Equity
14.11%
Return on Assets
4.85%
Financial Health
Current Ratio
1.41
Debt to Equity
88.87
Beta
0.72
Per Share Data
EPS (TTM)
$1.53
Book Value per Share
$11.19
Revenue per Share
$73.53
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
pdco | 2.8B | 20.48 | 2.80 | 14.11% | 2.13% | 88.87 |
McKesson | 84.2B | 27.10 | -100.73 | -194.51% | 0.84% | -11.52 |
Cencora | 56.7B | 33.80 | 55.93 | 141.78% | 0.55% | 827.73 |
Henry Schein | 8.2B | 21.79 | 2.40 | 8.12% | 3.05% | 68.55 |
Cardinal Health | 35.7B | 23.20 | -13.52 | -59.26% | 0.70% | -3.56 |
Owens & Minor | 408.6M | -1.11 | -1.44 | -148.42% | -11.18% | -7.48 |
Financial data is updated regularly. All figures are in the company's reporting currency.